Plegicol

Plegicol

citicoline

Manufacturer:

Ikapharmindo
Full Prescribing Info
Contents
Citicoline.
Description
Each mL ampoule contains: Citicoline 125 mg.
Indications/Uses
Unconsciousness due to brain damage, head injury or brain surgery & cerebral infarction. Accelerates rehabilitation of upper extremities in apoplectic hemiplegic patients. Mild lower extremities paralysis w/in 1 yr & receiving usual oral treatment. Manage the reduction of cognitive function in elderly.
Dosage/Direction for Use
Unconsciousness due to head injury or brain surgery: 500 mg drip or IV 1-2 times daily. Unconsciousness in acute cerebral infarction: 1,000 mg IV once daily continuously for 2 wk. Post-apoplectic hemiplegia: 1,000 mg IV once daily continuously for 4 wk. Continue treatment for additional 4 wk if there is tendency of recovery.
Contraindications
Hypertonia of the parasympathetic nervous system.
Special Precautions
Acute, severe & progressive consciousness disturbance; concomitant therapy w/ hemostatic or intracranial pressure-relieving drugs or use of measures to keep body temp low. Avoid high doses in intracranial bleeding.
Side Effects
Epigastric distress, nausea, skin redness, headache, dizziness.
Drug Interactions
Phenytoin effect is reduced in the presence of alcohol and phenobarbitone.
Storage
Store at temperatures below 25°C and dry.
ATC Classification
N06BX06 - citicoline ; Belongs to the class of other psychostimulants and nootropics.
Presentation/Packing
Inj (amp) 125 mg/mL x 4 mL x 5's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in